Biological Sensor

• US 20020192637A1
• Filed: 06/20/2002
• Published: 12/19/2002
• Est. Priority Date: 12/20/1999
• Status: Abandoned Application

• Current Assignee: Qinetiq Limited (QinetiQ Group PLC)
• Original Assignee: Qinetiq Limited (QinetiQ Group PLC)
• Inventors: Parsons, Alan T, Heal, Richard D A
• Application Number:
  US10/168,321
• Publication Number:
  US 20020192637A1
• Time in Patent Office: Days
• US Class Current: 435/4
• CPC Class Codes: G01H 11/06 by electric means
• CPC Class Codes: G01H 17/00 Measuring mechanical vibrations or ultrasonic, sonic or infrasonic waves, not provided for in the preceding groups see provisionally also G01H1/00
• CPC Class Codes: G01N 33/5008 for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
• CPC Class Codes: G01N 33/502 for testing non-proliferative effects
• CPC Class Codes: G01N 33/5058 Neurological cells

Abstract

A biological sensor, especially a barosensor, which can be operated using a neuronal network, is described. Neuronal cultures suitable for use in such a sensor are also described.

Claims

1. A method of detecting changes in pressure comprising providing an apparatus comprising living neuronal cells contacting a substrate comprising a plurality of electrodes, exposing said cells to changes in pressure and recording resulting changes in the electrical activity of said cells.

4. The method of claim 1 or the sensing apparatus according to either of claims 2 or 3, characterised in that said changes in pressure constitute acoustic signals.

5. The method of claim 1 or the sensing apparatus according to either of claims 2 or 3, characterised in that said neuronal cells are selected from the group comprising primary dorsal root ganglion cells, ND7/23 cells, neuromast cells, P-cells, stretch receptor cells, nodose cells, Merckel cells, phaeochromocytoma cells, Immortomouse cells and hair cells.

2. Sensing apparatus comprising living neuronal cells in a fluid medium, a substrate comprising a plurality of electrodes with which said cells are in contact, and means of detecting the electrical activity of said cells via said electrodes, characterised in that external changes in pressure are transmitted to the fluid medium resulting in detectable changes in the pattern of electrical activity of said cells.

3. Sensing apparatus according to claim 2, characterised in that external changes in pressure are transmitted to said medium by means of a diaphragm.

6. A method of detecting one or more antibiotics comprising providing an apparatus comprising living neuronal cells contacting a substrate comprising a plurality of electrodes, exposing said cells to said antibiotics and recording resulting changes in the electrical activity of said cells, characterised in that said antibiotics are of a class selected from a group comprising aminoglycosides, cyclic amines or DAB-amines.

10. The method of claim 6 or 7, or the sensing apparatus according to claim 8 or 9, characterised in that said neuronal cells are selected from the group comprising hippocampal cells, primary dorsal root ganglion cells, ND7/23 cells, neuromast cells, P-cells, stretch receptor cells, nodose cells, Merckel cells, phaeochromocytoma cells, Immortomouse cells and hair cells.

11. The method according to claim 6 or 7, or the sensing apparatus according to claim 8 or 9, characterised in that said antibiotics are selected from the group comprising;

streptomycin, GENETICIN®

, kanamycin, neomycin, lincomycin, tetracycline, or polymyxin B.

7. A method of detecting antibiotics comprising providing an apparatus comprising living neuronal cells contacting a substrate comprising a plurality of electrodes, exposing said cells to said antibiotics and recording resulting changes in the electrical activity of said cells, characterised in that said cells are exposed to two or more antibiotics.

8. Sensing apparatus comprising living neuronal cells in a fluid medium, a substrate comprising a plurality of electrodes with which said cells are in contact, and means of detecting the electrical activity of said cells via said electrodes, characterised in that presence of one or more antibiotics selected from a group comprising aminoglycosides, cyclic amines and DAB-amines in the fluid medium results in detectable changes in the pattern of electrical activity of said cells.

12. A drug screening method using the apparatus of either of claims 8 or 9.

9. Sensing apparatus comprising living neuronal cells in a fluid medium, a substrate comprising a plurality of electrodes with which said cells are in contact, and means of detecting the electrical activity of said cells via said electrodes, characterised in that presence of two or more antibiotics in the fluid medium results in detectable changes in the pattern of electrical activity of said cells.